Compounds > captopril
Page last updated: 2024-08-23

captopril and Prostatic Hyperplasia

captopril has been researched along with Prostatic Hyperplasia in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Azab, SS; El-Demerdash, E; Mantawy, EM; Mostafa, F1
Himmel, W; Kochen, MM; Lönker, B1
Fabiani, ME; Frauman, AG; Johnston, CI; Sourial, M; Thomas, WG1

Other Studies

3 other study(ies) available for captopril and Prostatic Hyperplasia

ArticleYear
The angiotensin converting enzyme inhibitor captopril attenuates testosterone-induced benign prostatic hyperplasia in rats; a mechanistic approach.
    European journal of pharmacology, 2019, Dec-15, Volume: 865

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Fibroblast Growth Factor 2; Gene Expression Regulation; Interleukin-8; Male; Prostatic Hyperplasia; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; RNA, Messenger; Testosterone; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A

2019
[Relevance of general practitioner's prescriptions for hospital pharmacotherapy. A survey of hospital physicians].
    Deutsche medizinische Wochenschrift (1946), 1996, Nov-22, Volume: 121, Issue:47

    Topics: Aged; Attitude of Health Personnel; Captopril; Data Interpretation, Statistical; Diabetes Mellitus; Drug Combinations; Drug Prescriptions; Drug Therapy; Family Practice; Female; Flavonoids; Ginkgo biloba; Hemostatics; Humans; Hydrochlorothiazide; Hypertension; Male; Medical Staff, Hospital; Middle Aged; Plant Extracts; Prostatic Hyperplasia; Sitosterols; Surveys and Questionnaires

1996
Angiotensin II enhances noradrenaline release from sympathetic nerves of the rat prostate via a novel angiotensin receptor: implications for the pathophysiology of benign prostatic hyperplasia.
    The Journal of endocrinology, 2001, Volume: 171, Issue:1

    Topics: Analysis of Variance; Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Captopril; CHO Cells; Cricetinae; Dose-Response Relationship, Drug; Imidazoles; Losartan; Male; Norepinephrine; Oligopeptides; Prostate; Prostatic Hyperplasia; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Sympathetic Nervous System; Synaptic Transmission

2001